Maravai LifeSciences (MRVI) Tops Q3 EPS by 3c

Maravai LifeSciences (NASDAQ: MRVI) reported Q3 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $191.3 million versus the consensus estimate of $195.4 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in